Colorectal cancer is one of the cancers where, if found early, it has a 91% chance of survival for the patient. If you find ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through ...
Rhythm’s ColoSTAT blood test for colorectal cancer accredited by The National Association of Testing Authorities ... Read ...
March is Colorectal Cancer Awareness Month. A new blood test offers an easier screening option for Tennesseans.
Michael Groves thought he had appendicitis. In January 2021, he went to the emergency department with abdominal pains, but ...
Guardant Health (NasdaqGS:GH) has launched the Shield Across America mobile screening tour to promote its FDA approved blood test for colorectal cancer. The tour is scheduled to reach more than 100 ...
The Canadian Cancer Society (CCS) is calling on provinces and territories to lower the start age of organized colorectal cancer screening programs to 45 for people at average risk, from the current ...
Dr. McDreamy has signed onto yet another cancer awareness initiative. | Dr. McDreamy has signed onto yet another cancer awareness initiative. “Grey’s Anatomy” star Patrick Dempsey, who has worked with ...
Patrick Dempsey, actor and cancer advocate, shares his experience getting screened for colorectal cancer with Shield by ...
With colon cancer deaths rising among younger adults and millions of eligible Americans skipping their colonoscopies, Guardant Health is taking its Shield blood test on the road in hopes of tackling ...
Rhythm Biosciences has reached a major milestone with the first commercial sale of its blood-based ColoSTAT colorectal cancer test. ... Read More The post Rhythm hits key milestone with first sale of ...
The gut bacterium Bacteroides fragilis has long presented researchers with a paradox. It has been associated with colorectal cancer, yet it also lives quite happily in most healthy people. A study by ...